Literature DB >> 10751366

Telomerase activity in melanocytic lesions: A potential marker of tumor biology.

P Rudolph1, C Schubert, S Tamm, K Heidorn, A Hauschild, I Michalska, S Majewski, G Krupp, S Jablonska, R Parwaresch.   

Abstract

Telomerase activation, being a cardinal requirement for immortalization, is a crucial step in the development of malignancy. With a view toward diagnostic and biological aspects in melanocytic neoplasia, we investigated the relative levels of telomerase activity in 72 nevi and 16 malignant melanomas by means of a modified telomeric repeat amplification protocol (TRAP) assay, including an internal amplification standard. We further compared telomerase activity with the expression of two different proliferation-specific proteins, Ki-67 and repp86, a protein expressed exclusively in the cell cycle phases S, G2, and M. Telomerase activity was associated with the overall growth fraction (Ki-67) but showed a closer correlation with the expression of repp86. Both telomerase activity and proliferation indices discriminated clearly between malignant melanomas and nevi, but not between common and dysplastic nevi. Nonetheless, a portion of nevi exhibited markedly elevated telomerase activity levels without proportionally increased proliferation. This was independent of discernible morphological changes. Clinicopathological correlations showed an association between high telomerase activity and early metastatic spread in melanomas, linking telomerase to tumor biology. Our results provide arguments in favor of an occasional progression from nevi to melanomas and imply that proliferation measurements in combination with telomerase assays may help to elicit early malignant transformation that is undetectable by conventional morphology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751366      PMCID: PMC1876875          DOI: 10.1016/S0002-9440(10)65011-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  70 in total

1.  Enhanced expression of Ki-67, topoisomerase IIalpha, PCNA, p53 and p21WAF1/Cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi.

Authors:  P Rudolph; M Tronnier; R Menzel; M Möller; R Parwaresch
Journal:  Hum Pathol       Date:  1998-12       Impact factor: 3.466

2.  Analysis of telomerase expression and proliferative activity in the different layers of cyclic endometrium.

Authors:  G Bonatz; W Klapper; A Barthe; K Heidorn; W Jonat; G Krupp; R Parwaresch
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

3.  Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype.

Authors:  X R Jiang; G Jimenez; E Chang; M Frolkis; B Kusler; M Sage; M Beeche; A G Bodnar; G M Wahl; T D Tlsty; C P Chiu
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

4.  Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome.

Authors:  M H Greene; W H Clark; M A Tucker; D E Elder; K H Kraemer; D Guerry; W K Witmer; J Thompson; I Matozzo; M C Fraser
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

5.  The dysplastic nevus.

Authors:  D E Elder
Journal:  Pathology       Date:  1985-04       Impact factor: 5.306

6.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

7.  Regulation of telomerase activity in quiescent immortalized human cells.

Authors:  W Klapper; K K Singh; K Heidorn; R Parwaresch; G Krupp
Journal:  Biochim Biophys Acta       Date:  1998-11-08

8.  Telomerase activity in radiation-induced chronic human skin ulcers.

Authors:  P Zhao; X Li; Z Yang; D Wang
Journal:  J Environ Pathol Toxicol Oncol       Date:  1999       Impact factor: 3.567

9.  Recognition and elongation of telomeres by telomerase.

Authors:  E H Blackburn; C W Greider; E Henderson; M S Lee; J Shampay; D Shippen-Lentz
Journal:  Genome       Date:  1989       Impact factor: 2.166

Review 10.  Telomerase in cancer: clinical applications.

Authors:  V Urquidi; D Tarin; S Goodison
Journal:  Ann Med       Date:  1998-10       Impact factor: 4.709

View more
  17 in total

Review 1.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

2.  Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.

Authors:  M Krams; A Claviez; K Heidorn; G Krupp; R Parwaresch; D Harms; P Rudolph
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 3.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

Review 4.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

5.  Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.

Authors:  Zhong-Ying Shen; Li-Yan Xu; En-Min Li; Wei-Jia Cai; Min-Hua Chen; Jian Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 6.  Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.

Authors:  M R Hussein
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

7.  Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.

Authors:  Matthias Krams; Barbara Hero; Frank Berthold; Reza Parwaresch; Dieter Harms; Pierre Rudolph
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 8.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

Review 9.  [The dysplastic nevus. Separate entity, melanoma precursor or diagnostic dilemma?].

Authors:  A Roesch; M Landthaler; T Vogt
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

10.  Flow cytometric analysis of DNA, telomerase content and multi-gene expression in esophageal epithelial dysplasia.

Authors:  Lian-Fu Zuo; Pei-Zhong Lin; Fing-Ying Qi; Jian-Wen Guo; Jiang-Hui Liu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.